Subaru Vivio

Ventric Health Named Best Digital/Mobile Health Solution in the Fierce Healthcare Innovation Awards 2023 for Its Vivio System™

Retrieved on: 
Wednesday, November 29, 2023
Economics, Patient, Algorithm, FDA, Heart failure, Diagnosis, Medicare, Pharmaceutical industry, Medical device, Subaru Vivio

PASADENA, Calif., Nov. 29, 2023 /PRNewswire/ -- Ventric Health, a healthcare technology company and medical device provider focused on cardiovascular health, today announced the Vivio System™ was named Best Digital/Mobile Health Solution in the prestigious Fierce Healthcare Innovation Awards 2023. Vivio®, a mobile, tech-enabled device aiding clinicians in heart failure diagnosis, is simple to use but sophisticated in function. Vivio uses advanced algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP) quickly and non-invasively.

Key Points: 
  • Device aiding noninvasive heart failure diagnosis chosen for the prestigious award based on its effectiveness, technical innovation, financial impact, and other judgment criteria
    PASADENA, Calif., Nov. 29, 2023 /PRNewswire/ -- Ventric Health, a healthcare technology company and medical device provider focused on cardiovascular health, today announced the Vivio System™ was named Best Digital/Mobile Health Solution in the prestigious Fierce Healthcare Innovation Awards 2023.
  • "This award underscores that healthcare innovation can transform outcomes and drive efficiency, positively impacting both patient well-being and the economics of care," said Sean Brady, co-founder and CEO at Ventric Health.
  • The Fierce Healthcare Innovation Awards program showcases outstanding innovation, driving improvements and transforming the industry.
  • To learn more about Vivio and how Ventric Health drives the tech-enabled revolution in detecting heart failure, visit the Vivio resource page .

Ventric Health Receives FDA 510(k) Clearance for Vivio®

Retrieved on: 
Wednesday, October 25, 2023
FDA, Food, Health, Medicare, Heart failure, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Catheter, Transthoracic echocardiogram, SDOH, Transport, Blood, Algorithm, ER, Patient, Diagnosis, Medical device, Pharmaceutical industry, Medical imaging, Subaru Vivio

PASADENA, Calif., Oct. 25, 2023 /PRNewswire/ -- Ventric Health, a healthcare technology company and medical device provider focused on cardiovascular health, today announced that its medical device, the Vivio System™, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). As a result, Vivio empowers clinicians to non-invasively diagnose heart failure within clinical and home health care environments. 

Key Points: 
  • PASADENA, Calif., Oct. 25, 2023 /PRNewswire/ -- Ventric Health, a healthcare technology company and medical device provider focused on cardiovascular health, today announced that its medical device, the Vivio System™, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
  • As a result, Vivio empowers clinicians to non-invasively diagnose heart failure within clinical and home health care environments.
  • Ventric Health co-founder Mory Gharib emphasized, "This is an indispensable clinical insight for clinicians in any care setting.
  • To learn more about Vivio and how Ventric Health is driving the tech-enabled revolution in detecting heart failure, visit the Vivio resource page .

White Paper Released at CCFA Summit: How Business Thrives in On-Demand Retail

Retrieved on: 
Wednesday, July 27, 2022
Association, Nasdaq, Sale, JDDJ, Omnichannel, Neglected tropical diseases, View, Accidental Death and Disability: The Neglected Disease of Modern Society, Industry, Kimberly-Clark, Walmart, Electronics, White paper, Solution, DADA, Marketing, Board, Multimedia, Director, Organization, CCFA, Policy, Creativity, ACE, JD.com, Efficiency, Consumer electronics, Report, Subaru Vivio, Growth, Dada, Infant, Consumption, Rail transport, Video game, Retail, Online shopping, Unilever

SHENZHEN, China, July 27, 2022 /PRNewswire/ -- Dada Group (Nasdaq: DADA)'s JDDJ and JD.com's Shop Now showed up at the "2022 China International Retail Innovation Summit". On-demand retail, as the megatrend in the retail industry as well as a new growth driver for retailers and brands, was the major topic and arose heated discussions among business leaders today.

Key Points: 
  • At the summit, Dada Group released the "White Paper On Open On-Demand Retail Platform Model" in collaboration with China Chain Store & Franchise Association (CCFA) and JD.com's Consumption and Industry Development Research Institute.
  • The White Paper offers a panoramic display of the open platform model of on-demand retail for the first time in industry.
  • Dr. PEI Liang, President of China Chain Store & Franchise Association, demonstrated: "On-demand retail is an important part of omni-channel retail.
  • Based on the successful cases, the White Paper provides a methodological sum-up dubbed "On-demand ACE", suggesting a route to success in on-demand retail.